U.S. Markets closed

Update on Eli Lilly’s Oncology Drugs Erbitux, Gemzar, Lartruvo

Daniel Collins
Update on Eli Lilly’s Oncology Drugs Erbitux, Gemzar, Lartruvo

An In-Depth Look at Eli Lilly in Fiscal 4Q17 and Fiscal 2017